Research Site

Manresa 8242

2 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer

Studies at this site

• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed